Judge Bounces Derivative Suit Against Cell Therapeutics

Law360, New York (September 12, 2006, 12:00 AM EDT) -- Months after tossing out a private class action against Cell Therapeutics Inc., a federal judge has dismissed a derivative lawsuit accusing the Seattle biopharmaceutical’s directors of making false statements regarding the success of its lung cancer drug XYOTAX.

U.S. District Judge Ricardo Martinez recently threw out the derivative lawsuit and barred the plaintiffs from reinstating the complaint, according to CTI.

The suit, filed in May 2005 in the U.S. District Court for the Western District of Washington, accused the company’s executives of breaching their duty and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.